GSK 'settles Avandia claims' on first day of safety hearing

Glaxosmithkline has agreed to pay up to $460m (£303m) to settle the majority of cases brought over its Avandia diabetes drug, which has been claimed to cause heart attacks and strokes, according to reports yesterday.

The drugs giant last night refused to comment on the reports, which came on the first day of a hearing into the safety of the treatment, held by the US Food and Drug Administration's scientific panel. During the proceedings in Washington yesterday, GSK was accused by the Senate Finance Committee of hiding negative trial data dating back as long as a decade ago.

"As far back as 2000, internal emails show that GSK executives sought to downplay scientific findings, which raise questions about the safety [of Avandia]," the committee said.

The panel was also reminded to "keep an open mind" on the drug's safety, however. Margaret Hamburg, the FDA commissioner, reminded her colleagues to "follow the science, wherever it leads, and the rest will fall into place".

GSK, Europe's biggest pharmaceutical company, has strenuously denied that it has hidden damaging data about Avandia, and that the drug is dangerous. Referring to news of a possible settlement, a spokeswoman last night said that the company never comments on ongoing litigation.

The company has settled some cases however, including a hearing that was scheduled for June. "We continue to prepare for trials later this year, and are fully prepared to defend any litigation because we are confident that when courts and juries look at actual clinical data, the manner in which we communicated with the FDA and physicians, and our openness in posting studies on our website, the facts will support our position," GSK said.

The group yesterday presented evidence in support of Avandia's safety on the first day of the long-awaited hearing. Lawyers representing thousands of patients who claim they suffered heart problems because of the drug are poring over documents released by the FDA last week.

These revealed that some FDA scientists are sceptical over the quality of a GSK study, called the Record study, which showed Avandia patients were no more likely to have heart problems than other diabetes sufferers. The trial "was inadequately designed and conducted to provide any reassurance", the FDA's Thomas Marciniak wrote. A different FDA scientist, however, came to an alternative conclusion, and GSK says it stands by the Record study and that a further five studies all concluded that Avandia was safe.

Avandia sales were worth $3bn in 2006, before an article written by Cleveland cardiologist Steven Nissen in the respected New England Journal of Medicine first cast doubts over its safety. In 2009, GSK made $1.2bn from Avandia sales.

PROMOTED VIDEO
News
ebookA unique anthology of reporting and analysis of a crucial period of history
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Account Manager - (Product & Account Management, Marketing)

£26000 - £30000 per annum + Benefits: Ashdown Group: Account Manager - (Produc...

Training/Learning and Development Coordinator -London

£28000 - £32000 per annum: Ashdown Group: Training/Learning and Development Co...

Training Programme Manager (Learning and Development)-London

£28000 - £32000 per annum + benefits: Ashdown Group: Training Programme Manage...

.NET Software Developer (.NET, C#, ASP.NET, front-end)

£30000 - £45000 per annum: Harrington Starr: A Global Financial Service Organi...

Day In a Page

A new Russian revolution: Cracks start to appear in Putin’s Kremlin power bloc

A new Russian revolution

Cracks start to appear in Putin’s Kremlin power bloc
Eugene de Kock: Apartheid’s sadistic killer that his country cannot forgive

Apartheid’s sadistic killer that his country cannot forgive

The debate rages in South Africa over whether Eugene de Kock should ever be released from jail
Standing my ground: If sitting is bad for your health, what happens when you stay on your feet for a whole month?

Standing my ground

If sitting is bad for your health, what happens when you stay on your feet for a whole month?
Commonwealth Games 2014: Dai Greene prays for chance to rebuild after injury agony

Greene prays for chance to rebuild after injury agony

Welsh hurdler was World, European and Commonwealth champion, but then the injuries crept in
Israel-Gaza conflict: Secret report helps Israelis to hide facts

Patrick Cockburn: Secret report helps Israel to hide facts

The slickness of Israel's spokesmen is rooted in directions set down by pollster Frank Luntz
The man who dared to go on holiday

The man who dared to go on holiday

New York's mayor has taken a vacation - in a nation that has still to enforce paid leave, it caused quite a stir, reports Rupert Cornwell
Best comedians: How the professionals go about their funny business, from Sarah Millican to Marcus Brigstocke

Best comedians: How the professionals go about their funny business

For all those wanting to know how stand-ups keep standing, here are some of the best moments
The Guest List 2014: Forget the Man Booker longlist, Literary Editor Katy Guest offers her alternative picks

The Guest List 2014

Forget the Man Booker longlist, Literary Editor Katy Guest offers her alternative picks
Jokes on Hollywood: 'With comedy film audiences shrinking, it’s time to move on'

Jokes on Hollywood

With comedy film audiences shrinking, it’s time to move on
It's the best of British art... but not all is on display

It's the best of British art... but not all is on display

Voted for by the British public, the artworks on Art Everywhere posters may be the only place where they can be seen
Critic claims 'I was the inspiration for Blanche DuBois'

Critic claims 'I was the inspiration for Blanche DuBois'

Blanche Marvin reveals how Tennessee Williams used her name and an off-the-cuff remark to create an iconic character
Sometimes it's hard to be a literary novelist

Sometimes it's hard to be a literary novelist

Websites offering your ebooks for nothing is only the latest disrespect the modern writer is subjected to, says DJ Taylor
Edinburgh Fringe 2014: The comedy highlights, from Bridget Christie to Jack Dee

Edinburgh Fringe 2014

The comedy highlights, from Bridget Christie to Jack Dee
Dame Jenny Abramsky: 'We have to rethink. If not, museums and parks will close'

Dame Jenny Abramsky: 'We have to rethink. If not, museums and parks will close'

The woman stepping down as chair of the Heritage Lottery Fund is worried